PHYMED INC
8-K, 2000-05-08
MEDICAL LABORATORIES
Previous: LINCOLN NATIONAL BOND FUND INC, 497, 2000-05-08
Next: FIDUCIARY CAPITAL GROWTH FUND INC, N-30D, 2000-05-08




                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                  -------------

                                    FORM 8-K

                                 CURRENT REPORT

     PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


                                   MAY 4, 2000
                        (Date of earliest event reported)

                                  PHYMED, INC.
             (Exact name of registrant as specified in its charter)


              OKLAHOMA                                    73-1457920
   (State or other jurisdiction of          (I.R.S. Employer Identification No.)
    incorporation or organization)

                                     0-10701
                            (Commission File Number)



                        9603 White Rock Trail, Suite 100
                               Dallas, Texas 75238
                    (Address of principal executive offices)

                                 (214) 340-9912
              (Registrant's telephone number, including area code)




<PAGE>

Item 4.  Changes in Registrant Certifying Accountant

         The Board of  Director  has  engaged  King,  Griffin & Adamson P. C. to
audit the  Registrant's  consolidated  financial  statements for the fiscal year
ended  December 31, 1999.  The  Registrant  has not  consulted the newly engaged
accountants  regarding  either any  accounting  principles  or the type of audit
opinion  that might be rendered on the  financial  statement  of the  Registrant
prior to their engagement.

         On March 28, 2000 the Registrant  filed an 8-K  terminating the auditor
of the past two fiscal years. As stated in that filing,  no  disagreements  were
related to their  termination as auditors.  Thus there were no  disagreements to
discuss with the newly engaged auditors.




Item 7.  Financial Statements and Exhibits

         (a)      Financial statements of business acquired.

                  Not applicable

         (b)      Proforma financial information

                  Not applicable

         (c)      Exhibits

                  Not applicable





                                       1

<PAGE>


                                   SIGNATURES

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned thereto duly authorized.

Date: March 4, 2000                    PHYMED, INC.
                                       (Registrant)

                                       /s/ George C. Barker
                                       --------------------
                                       George C. Barker,
                                       President and Chief Executive Officer




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission